Serinus Biosciences is a biotechnology company building the next generation of molecular glue therapeutics against high-value and hard-to-drug targets in oncology and immunology using the ApoXY platform. 
ApoXY is the first technology capable of systematically mapping the chemically inducible interactome of any protein as a massively multiplexed, AI-integrated cellular screening technology with unprecedented scale.
Serinus is building an internal pipeline of therapeutic assets against validated and previously undruggable targets with a growing library of proprietary molecular glues.

Serinus Biosciences

Org chart

Teams

Offices

Serinus Biosciences

Org chart

Teams

Offices

Related companies